Cargando…
IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine
Autores principales: | Abdel-Qader, Derar H., Hazza Alkhatatbeh, Issa, Hayajneh, Wail, Annab, Hassan, Al Meslamani, Ahmad Z., Elmusa, Reem A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942577/ https://www.ncbi.nlm.nih.gov/pubmed/35339305 http://dx.doi.org/10.1016/j.vaccine.2022.03.003 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: IgA nephropathy: case report
Publicado: (2022) -
COVID-19-Vaccine-Pfizer-BioNTech: IgA nephropathy: case report
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Haematuria and exacerbation of IgA nephropathy: 2 case reports
Publicado: (2021) -
Covid-19-vaccine-Pfizer-BioNTech/mRNA-1273: IgA nephropathy and reactivation of glomerulonephritis: 4 case reports
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Membranous nephropathy: case report
Publicado: (2021)